Denali Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-29,200	Closed	-$263K	–	507
2023 Q2	$263K	Buy	29,200 +23,400	+403%	+$211K	0.09%	194
2023 Q1	$45.6K	Sell	5,800 -5,000	-46%	-$39.3K	0.02%	229
2022 Q4	$73K	Buy	+10,800	New	+$73K	0.03%	188